Delaware's adult-use cannabis market posted its highest monthly sales in July at $2.8 million, yet the figure falls short of initial revenue projections as the state's rollout continues to face operational hurdles.
The July numbers represent a 12% increase from June sales, according to data from the Delaware Division of Alcohol and Tobacco Enforcement. But industry observers note the growth trajectory remains well below what state officials anticipated when Delaware legalized recreational cannabis in April 2023.
The gap between expectations and reality stems from two key factors: chronic licensing delays for retail-only dispensaries and pricing that makes neighboring states more attractive to Delaware consumers.
Retail Bottleneck
Delaware currently operates with just four dispensaries serving the adult-use market—all of them medical marijuana facilities that added recreational sales. The state has yet to approve any retail-only licenses, a category that was supposed to expand access and drive competition.
"We're seeing demand, but we're not capturing all of it," said John Flowers, executive director of the Delaware Cannabis Advocacy Network. "When you only have four locations and prices run 20-30% higher than Pennsylvania or New Jersey, people are going to drive across the border."
The Division of Alcohol and Tobacco Enforcement has received over 100 applications for retail-only licenses but has not issued a timeline for approvals. State officials cited the need for thorough background checks and facility inspections.
Delaware's medical-turned-recreational dispensaries also face inventory constraints. Product selection remains limited compared to mature markets, with some locations experiencing stock shortages on popular items like vape cartridges and edibles.
Border Competition
Delaware's compact geography works against its cannabis market. The entire state sits within a 30-minute drive of either Pennsylvania or New Jersey, both of which offer lower prices and more product variety.
A gram of premium flower in Delaware averages $18-20, compared to $12-15 in Pennsylvania dispensaries just across the state line. New Jersey's market, now in its third year, has seen aggressive price competition that Delaware cannot yet match.
"We're losing customers to Pennsylvania Medical Marijuana Program cardholders who can access lower prices, and New Jersey's recreational market has matured to the point where they're offering deals Delaware can't compete with," Flowers said.
The state's 15% excise tax on recreational cannabis, combined with the standard sales tax, adds to the pricing disadvantage.
Revenue Reality Check
When Delaware lawmakers debated legalization, fiscal estimates projected first-year adult-use sales could reach $50-60 million. At the current pace—roughly $15 million annualized based on recent months—the market would need to nearly quadruple to hit those targets.
Tax revenue has similarly disappointed. Delaware collected approximately $420,000 in cannabis excise taxes in July, bringing the total since recreational sales began in late March to just under $1.5 million.
Those figures pale in comparison to New Jersey, which collected $35 million in cannabis taxes in July alone, or Pennsylvania's medical program, which generates over $3 million monthly despite serving a patient-only market.
What Comes Next
State officials maintain that market growth will accelerate once retail-only licenses are issued. The Division of Alcohol and Tobacco Enforcement said it expects to announce the first wave of retail approvals before year-end, though it has missed previous self-imposed deadlines.
Industry advocates are pushing for expedited licensing and regulatory changes to improve price competitiveness. A bill introduced in the state legislature would reduce the excise tax to 10% and allow dispensaries to offer promotional discounts, currently prohibited under Delaware's cannabis regulations.
"The bones of a good market are here," Flowers said. "We just need to execute on licensing and give businesses the flexibility to compete. Otherwise, we're just subsidizing Pennsylvania and New Jersey's tax revenue."
The next test will be August sales figures, expected to be released in mid-September. Industry watchers will look for signs that summer tourism provided a boost, or whether the trend of modest growth continues.
This article is based on original reporting by mjbizdaily.com.
